Director Shareholding

Date : 12/06/2002 @ 5:29AM
Source : UK Regulatory (RNS and others)
Click here for ADVFN's up to the minute news service. Access our extensive collection of financial news from around the world including US, Europe and Asia.
<< Back

 



Director Shareholding

RNS Number:7558E
Powderject Pharmaceuticals PLC
6 December 2002


                       DEALINGS BY DIRECTORS


1)  NAME OF COMPANY

POWDERJECT PHARMACEUTICALS PLC

2)  NAME OF DIRECTOR

MR RICHARD SPIZZIRRI

3)  Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder
    if it is a holding of that person's spouse or children under the
    age of 18 or in respect of an non-beneficial interest

SHAREHOLDER NAMED IN 2 ABOVE

4)  Name of the registered holder(s) and, if more than one holder, the
    number of shares held by each of them. (If notified)

MR RICHARD SPIZZIRRI

5)  Please state whether notification relates to a person(s) connected
    with the Director named in 2 above and identify the connected person(s)



6)  Please state the nature of the transaction. For PEP transactions
    please indicate whether general/single co PEP and if discretionary/non
    discretionary

PURCHASE

7)  Number of shares/amount of
    stock acquired

61,000

8)   (0.067%)
    of issued Class



9)  Number of shares/amount
    of stock disposed



10)  ( N/A %)
    of issued Class



11) Class of security

ORDINARY 10P SHARES

12) Price per share

380.0 PENCE

13) Date of transaction

5 DECEMBER 2002

14) Date company informed

5 DECEMBER 2002

15) Total holding following this notification

61,000

16) Total percentage holding of issued class following this notification

0.067%

     IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE
                    COMPLETE THE FOLLOWING BOXES

17) Date of grant



18) Period during which or date on which exercisable



19) Total amount paid (if any) for grant of the option



20) Description of shares or debentures involved: class, number.



21) Exercise price (if fixed at time of grant) or indication that price
    is to be fixed at time of exercise



22) Total number of shares or debentures over which options held
    following this notification



23) Any additional information



24) Name of contact and telephone number for queries

ZOE EVANS - 01865 332600

25) Name and signature of authorised company official responsible for
    making this notification

    Date of Notification  6 DECEMBER 2002                                 



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSMGMGZLVKGZZG
<< Back


Powderject Pharm Historical Chart Powderject Pharm Intraday Chart  
Period


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
32 site:2us 091124 10:35 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )